Adage Capital Partners
BNTX icon

Adage Capital Partners’s BioNTech BNTX Stock Holding History

Adage Capital Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-57,500
Closed -$6.83M – 887
2024
Q3 		$6.83M Buy
+57,500
New +$5.29M 0.01% 679
2020
Q4 		– Sell
-250,000
Closed -$17.3M – 818
2020
Q3 		$17.3M Buy
+250,000
New +$17.9M 0.04% 415

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners's BNTX Position: Q4 2024 in Review

Adage Capital Partners sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 57,500 shares — an estimated $6.83M sold.

Adage Capital Partners first reported a position in BNTX in Q3 2020 and held it in 2 quarters. The position peaked at $17.3M in Q3 2020. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Adage Capital Partners reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • Adage Capital Partners sold 57,500 BioNTech shares in Q4 2024, an estimated $6.83M.
  • Adage Capital Partners first reported a position in BioNTech in Q3 2020 and held it in 2 quarters.
  • Adage Capital Partners's BioNTech position peaked at $17.3M in Q3 2020.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.